Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sumitomo to Boost R&D Investment, Build Overseas Marketing Systems
July 14, 2003
- Total Fertility, Natural Increase in Population at Record Lows
July 14, 2003
- Daiichi Suntory Pharma to See Steady Growth After FY2007
July 14, 2003
- REGULATORY NEWS IN BRIEF
July 14, 2003
- Asahi Kasei Reinforces GE Line-up in Major Fields
July 14, 2003
- Aeon Welcia Stores Breaks Off Relations with Drug Eleven
July 14, 2003
- 10-Year Data Protection Unnecessary: EMA
July 14, 2003
- AJD: Ordinary Profits Fall 24% Despite Slight Sales Increase
July 14, 2003
- Ohara Confident of Overcoming Sankyo's Patents on Mevalotin
July 14, 2003
- DIAGNOSTIC NEWS IN BRIEF
July 14, 2003
- ON THE MOVE
July 14, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 14, 2003
- Drug Industry Calls For Budget, Tax Reforms to Strengthen Its Competitiveness
July 14, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
July 14, 2003
- Versions of Mevalotin, Lipovas Launched by All 4 Top GE Houses
July 14, 2003
- Tsuruha: Sales Increase 14.8% to \116 Bil.
July 14, 2003
- BUSINESS NEWS IN BRIEF
July 14, 2003
- BULLETIN
July 14, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
July 14, 2003
- Gatiflo Makes Dainippon Revise Mid-term Plan: President Miyatake
July 14, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…